Theravance Biopharma, Inc. Purchase Agreements
2 Contracts & Agreements
- Equity Purchase and Funding Agreement, dated as of July 13, 2022, by and between Theravance Biopharma, Inc. and Royalty Pharma Investments 2019 ICAV (Filed With SEC on July 14, 2022)
- Asset Purchase Agreement, dated as of November 1, 2018, by and among Cumberland Pharmaceuticals Inc. on the one hand, and Theravance Biopharma Ireland Limited and Theravance... (Filed With SEC on November 16, 2018)